This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rousseau-Merck, M.-F. Articles by Aurias, A. Search for Related Content PubMed PubMed Citation Articles by Rousseau-Merck, M.-F. Articles by Aurias, A.

hSNF5/INI1 Inactivation Is Mainly Associated with Homozygous Deletions and Mitotic Recombinations in Rhabdoid Tumors¹

Pathologie Moléculaire des cancers INSERM U509 [M-F. R-M., I. V., I. L., A. M., O. D., A. A.] and Unité de Cytogénétique Oncologique [J. C.], Institut Curie, 75248 Paris cedex 05, France

The chromatin-remodeling hSNF5/INI1 gene has recently been shown to act as a tumor suppressor gene in rhabdoid tumors (RTs). In an attempt to further characterize the main chromosomal mechanisms involved in hSNF5/INI1 inactivation in RTs, we report here the molecular cytogenetic data obtained in 12 cell lines harboring hSNF5/INI1 mutations and/or deletions in relation to the molecular genetic analysis using polymorphic markers extended to both extremities of chromosome 22q. On the whole, mitotic recombination occurring in the proximal part of chromosome 22q, as demonstrated in five cases, and nondisjunction/duplication, highly suspected in two cases (processes leading respectively to partial or complete isodisomy), appear to be major mechanisms associated with hSNF5/INI1 inactivation. Such isodisomy accompanies each of the RTs exhibiting two cytogenetically normal chromosomes 22. This results in homozygosity for the mutation at the hSNF5/INI1 locus. An alternate mechanism accounting for hSNF5/INI1 inactivation observed in these tumors is homozygous deletion in the rhabdoid consensus region. This was observed in each of the four tumors carrying a chromosome 22q abnormality and, in particular, in the three tumors with chromosomal translocations. Only one case of our series illustrates the mutation/deletion classical model proposed for the double-hit inactivation of a tumor suppressor gene.

This article has been cited by other articles:

				T. Fujita, J. Igarashi, E. R. Okawa, T. Gotoh, J. Manne, V. Kolla, J. Kim, H. Zhao, B. R. Pawel, W. B. London, et al. CHD5, a Tumor Suppressor Gene Deleted From 1p36.31 in Neuroblastomas J Natl Cancer Inst, July 2, 2008; 100(13): 940 - 949. [Abstract] [Full Text] [PDF]

				S. Glaros, G. M. Cirrincione, A. Palanca, D. Metzger, and D. Reisman Targeted Knockout of BRG1 Potentiates Lung Cancer Development Cancer Res., May 15, 2008; 68(10): 3689 - 3696. [Abstract] [Full Text] [PDF]

				Y. Katsumi, Y. Kuwahara, S. Tamura, K. Kikuchi, O. Otabe, K. Tsuchiya, T. Iehara, H. Kuroda, H. Hosoi, and T. Sugimoto Trastuzumab Activates Allogeneic or Autologous Antibody-Dependent Cellular Cytotoxicity against Malignant Rhabdoid Tumor Cells and Interleukin-2 Augments the Cytotoxicity Clin. Cancer Res., February 15, 2008; 14(4): 1192 - 1199. [Abstract] [Full Text] [PDF]

				C. J. Guidi, R. Mudhasani, K. Hoover, A. Koff, I. Leav, A. N. Imbalzano, and S. N. Jones Functional Interaction of the Retinoblastoma and Ini1/Snf5 Tumor Suppressors in Cell Growth and Pituitary Tumorigenesis Cancer Res., August 15, 2006; 66(16): 8076 - 8082. [Abstract] [Full Text] [PDF]

				P. Modena, E. Lualdi, F. Facchinetti, L. Galli, M. R. Teixeira, S. Pilotti, and G. Sozzi SMARCB1/INI1 Tumor Suppressor Gene Is Frequently Inactivated in Epithelioid Sarcomas Cancer Res., May 15, 2005; 65(10): 4012 - 4019. [Abstract] [Full Text] [PDF]

				T. M. Tekautz, C. E. Fuller, S. Blaney, M. Fouladi, A. Broniscer, T. E. Merchant, M. Krasin, J. Dalton, G. Hale, L. E. Kun, et al. Atypical Teratoid/Rhabdoid Tumors (ATRT): Improved Survival in Children 3 Years of Age and Older With Radiation Therapy and High-Dose Alkylator-Based Chemotherapy J. Clin. Oncol., March 1, 2005; 23(7): 1491 - 1499. [Abstract] [Full Text] [PDF]

				A. Wild, P. Langer, A. Ramaswamy, B. Chaloupka, and D. K. Bartsch A Novel Insulinoma Tumor Suppressor Gene Locus on Chromosome 22q with Potential Prognostic Implications J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5782 - 5787. [Abstract] [Full Text] [PDF]

				P. J. E. Quintana, E. A. H. Neuwirth, and A. J. Grosovsky Interchromosomal Gene Conversion at an Endogenous Human Cell Locus Genetics, June 1, 2001; 158(2): 757 - 767. [Abstract] [Full Text] [PDF]